Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Delirium: Is Prophylactic Drug Therapy Useful in High Risk Patients as Defined by the Delirium Risk Prediction Model?

NCT03199950 is registered in ClinicalTrials.gov with Zuyderland Medisch Centrum as lead sponsor.

NCT NCT03199950
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03199950 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Delirium: Is Prophylactic Drug Therapy Useful in High Risk Patients as Defined by the Delirium Risk Prediction Model?
Lead sponsor
Zuyderland Medisch Centrum
Phase
Phase 4
Overall status
Unknown status
Start date
June 23, 2017
Completion date
November 23, 2018
Enrollment
1,366 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

delirium